2021
DOI: 10.3389/fphar.2021.655063
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines

Abstract: Background: The outbreak of new coronavirus has tremendously threatened the public health system worldwide, including China. Chinese patent medicines (CPMs) have greatly contributed to the prevention and treatment of this viral infection, as well as the recovery of patients with COVID-19 infection. Therefore, numerous experts and guidelines recommend to take CPMs to treat pneumonia due to COVID-19.Aim of the Study: The present study reviewed CPMs recommended by the < Guidelines for diagnosis and managem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 78 publications
(37 reference statements)
0
11
0
Order By: Relevance
“…Apricots are ingredients of two traditional Chinese medicines—Jinhuaqinggan granules and Lianhuaqinwen capsule/granules—which are used in combination with conventional medicines in the treatment of viral infections [ 13 ]. In Korea, the seeds are used to treat cough, phlegm and the common cold.…”
Section: Traditional and Ethnomedicinal Importancementioning
confidence: 99%
“…Apricots are ingredients of two traditional Chinese medicines—Jinhuaqinggan granules and Lianhuaqinwen capsule/granules—which are used in combination with conventional medicines in the treatment of viral infections [ 13 ]. In Korea, the seeds are used to treat cough, phlegm and the common cold.…”
Section: Traditional and Ethnomedicinal Importancementioning
confidence: 99%
“…Additionally, traditional Chinese medicine is widely used in the treatment of COVID-19 in China (Liang et al, 2021;Wu and Zhong, 2021). Jingyin granules and Qingfei Paidu decoction, have been recommended for treating the H1N1 influenza A virus infection and COVID-19 in China, and have exhibited an inhibitory effect on CYP1A, CYP2A6, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP2C19 and CYP3A (Zhang et al, 2021b;Zhang et al, 2021c).…”
Section: Pharmacological Therapy For Comorbiditymentioning
confidence: 99%
“…In addition, XNJ can be used alone or as an adjuvant therapy to reduce brain damage and improve nerve health for the treatment of acute cerebral hemorrhage [ 132 ] and traumatic craniocerebral injury [ 133 , 134 ]. During the COVID-19 epidemic, the National Health Commission of the People's Republic of China listed XNJ as a recommended traditional Chinese medicine injection in the “Guidelines for the Diagnosis and Management of COVID-19 (8th Edition)” [ 135 ]. For patients with severe symptoms, the Angong Niuhuang Pill is also recommended [ 135 ].…”
Section: Research On Formulas Containing Both Cinnabar and Realgarmentioning
confidence: 99%
“…During the COVID-19 epidemic, the National Health Commission of the People's Republic of China listed XNJ as a recommended traditional Chinese medicine injection in the “Guidelines for the Diagnosis and Management of COVID-19 (8th Edition)” [ 135 ]. For patients with severe symptoms, the Angong Niuhuang Pill is also recommended [ 135 ].…”
Section: Research On Formulas Containing Both Cinnabar and Realgarmentioning
confidence: 99%